Riccio Orbicia, van Gijn Marielle E, Bezdek April C, Pellegrinet Luca, van Es Johan H, Zimber-Strobl Ursula, Strobl Lothar J, Honjo Tasuku, Clevers Hans, Radtke Freddy
Ecole Polytechnique Fédérale de Lausanne, Swiss Institute for Experimental Cancer Research, Chemin des Boveresses 155, Epalinges 1066, Switzerland.
EMBO Rep. 2008 Apr;9(4):377-83. doi: 10.1038/embor.2008.7. Epub 2008 Feb 15.
The crucial role of individual Notch receptors and the mechanism by which they maintain intestinal crypt progenitor cells were assessed by using a series of inducible gut-specific Notch mutant mice. We found that Notch1 and Notch2 receptors function redundantly in the gut, as only simultaneous loss of both receptors results in complete conversion of proliferating crypt progenitors into post-mitotic goblet cells. This conversion correlates with the loss of Hes1 expression and derepression of the cyclin-dependent kinase (CDK) inhibitors p27Kip1 and p57Kip2. We also found that the promoter of both CDK inhibitor genes is occupied by the Notch effector Hes1 in wild-type crypt progenitor cells. Thus, our results indicate that Notch-mediated Hes1 expression contributes to the maintenance of the proliferative crypt compartment of the small intestine by transcriptionally repressing two CDK inhibitors.
通过使用一系列可诱导的肠道特异性Notch突变小鼠,评估了个体Notch受体的关键作用及其维持肠道隐窝祖细胞的机制。我们发现Notch1和Notch2受体在肠道中功能冗余,因为只有这两种受体同时缺失才会导致增殖的隐窝祖细胞完全转化为有丝分裂后的杯状细胞。这种转化与Hes1表达的丧失以及细胞周期蛋白依赖性激酶(CDK)抑制剂p27Kip1和p57Kip2的去抑制相关。我们还发现,在野生型隐窝祖细胞中,两种CDK抑制剂基因的启动子都被Notch效应器Hes1占据。因此,我们的结果表明,Notch介导的Hes1表达通过转录抑制两种CDK抑制剂,有助于维持小肠增殖性隐窝区室。